期刊
ANNALS OF ONCOLOGY
卷 27, 期 7, 页码 1354-1356出版社
OXFORD UNIV PRESS
DOI: 10.1093/annonc/mdw148
关键词
-
类别
Unexpected severe exacerbation or manifestation of primary disease related to nivolumab was noted in non-small-cell lung cancer (NSCLC) patients with a poor performance status or central nervous system metastases. Thus, we should monitor these patients when they are administered nivolumab.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据